OPEN END TURBO CALL WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 13:27:50 2024-05-31 EDT | ||
| 0.8 EUR | +3.90% |
|
| 1 month | +50.94% | ||
| 3 months | +40.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.8 | +3.90% |
| 24-05-30 | 0.77 | +6.94% |
| 24-05-29 | 0.72 | -2.70% |
| 24-05-28 | 0.74 | -5.13% |
| 24-05-27 | 0.78 | -3.70% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 01:27 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH148L |
| ISIN | DE000UH148L2 |
| Date issued | 2021-09-03 |
| Strike | 218.9 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.35 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.04 € |
|---|---|
| Lowest since issue | 0.038 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
